ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 836

Comprehensive Behavioral Intervention Compared To Standard Of Care Exercise Program After Total Knee Arthroplasty: A Pilot Randomized Trial

Sara R. Piva1, Maria Beatriz Catelani1 and Gustavo J. Almeida2, 1Physical Therapy, University of Pittsburgh, Pittsburgh, PA, 2Department of Physical Therapy, University of Pittsburgh, Pittsburgh, PA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: physical activity and physical function, Total Knee Arthroplasty (TKA)

  • Tweet
  • Email
  • Print
Session Information

Title: ARHP Noteworthy Abstracts

Session Type: Abstract Submissions (ARHP)

Background/Purpose: Although the overall outcome of total knee arthroplasty (TKA) is favorable, surgery alone fails to resolve many of the substantial functional limitations and physical inactivity that began long before the surgery. To improve these persistent limitations, exercise programs need to be performed at doses sufficiently high to promote sizable improvements in physical function (PF). In addition, physical activity (PA) promotion should be part of the rehab program. The aim of this study was to determine the effectiveness of comprehensive behavioral intervention (CBI) – that uses intense exercises and promotes activity participation – compared to a standard of care (SC) exercise program to improve PF and PA in patients after TKA.

Methods: Double blinded pilot randomized clinical trial. Patients who underwent unilateral TKA 3 – 6 months prior were assigned into 2 groups, the CBI or SC. Subjects in both groups completed 12 weeks of supervised exercise followed by 12 weeks of exercise program.  Clinical outcomes were collected prior to (baseline) and after intervention (6 months). Self-reported PF was measured by the Western Ontario and McMaster Universities Arthritis Index- PF score (WOMAC-PF) and the PF subscale of the RAND-36. Patient-identified problem areas in daily functioning were measured by the Canadian Occupational Performance Measure (COPM), which considers both the importance and the satisfaction with the performance areas.   Performance-based PF was measured by the chair-raise test, gait velocity, and the stair climbing test. An objective accelerometer-based monitor was used to quantify PA during light (2 to 2.99 metabolic equivalents – METs) and moderate intensities (above 3 METs). Changes between groups were compared using independent sample t-test or Wilcoxon according with data distribution.

Results: Sample included 44 subjects (70% female, age 68 ± 0.98 years, and BMI 30.0 ± 0.6 Kg/m2). Results are reported in the Table. Both groups reported improved PF. PF measured by the RAND-36 was statistically significant larger in the CBI than in the SC, whereas group differences in the WOMAC- PF did not reach significance. Both groups improved performance and satisfaction in the COPM. Subjects in the CBI group significantly improved in the Stair Climb test compared to the SC group. Group differences in gait velocity and chair-raise test were not significant. While not significant, subjects in the SC group decreased PA while the ones in the CBI increased PA.

Conclusion: Subjects in the CBI group experienced larger improvements in PF as measured by the RAND-36 and the stair climbing test. Although we observed a trend towards larger changes in COPM-satisfaction and light intensity PA in the CBI group, the negative results may be due to the small sample of this pilot study.  Results indicate that the CBI may be a promising intervention for patients post TKA.

Table.  Baseline and 6-month physical function and physical activity outcomes in the CBI and SC groups. Data represent mean ± SD or median (Q25; Q75).

 

Group

Baseline

6 months

Change

(6 mo – baseline)

 

Percentage Change

p-value

WOMAC – Physical Function*

SC

17.68 ± 2.21

12.8 ± 2.42

-5.35 ± 2.09

-30%

0.503

CBI

19.09 ± 1.99

11.42 ± 1.50

-7.05 ± 1.34

– 37%

RAND-36 – Physical Function**

SC

66.14 ± 3.97

70.25 ± 5.41

6.75 ± 3.86

10%

0.037

CBI

56.14 ± 4.80

76.05 ± 3.74

16.58 ± 2.30

30%

COPM – Performance**

SC

36.38 ± 2.71

59.74 ± 5.74

23.18 ± 4.48

64%

0.360

CBI

34.27 ± 3.16

63.34 ± 4.70

29.0 ± 4.39

85%

COPM – Satisfaction**

SC

27.63 ± 3.26

56.70 ± 6.78

28.62 ± 5.50

104%

0.176

CBI

22.36 ± 2.74

61.93 ± 5.37

39.15 ± 5.27

175%

Chair-raise Test (sec)

SC

13.16 ± 0.68

13.74 ± 1.67

0.68 ± 1.53

5%

0.444

CBI

14.26 ± 0.81

11.97 ± 0.63

-1.69 ± 0.40

– 12%

Gait Velocity (m/sec)

SC

1.106 ± 0.38

1.183 ± 0.06

0.06 ± 0.04

6%

0.679

CBI

1.037 ± 0.04

1.147 ± 0.04

0.08 ± 0.03

8%

Stair Climbing Test (sec)

SC

15.5 ± 0.997

15.59 ± 1.66

0.07 ± 1.47

0.5%

0.006

CBI

19.03 ± 1.54

14.19 ± 0.98

-4.43 ± 1.00

– 23%

Light Intensity PA  (min/d)

SC

123.5

(82.5; 176.8)

83.5

(42.0; 158.0)

-5.5

(-62.8; 14.0)

– 5%

0.167

CBI

99.5

(44.8; 157.5)

124.0

(61.0; 142.0)

12.0

(-26.0; 21.0)

12%

Moderate Intensity PA (min/d)

SC

38.5

(18.3; 70.8)

33.0

(17.3; 61.8)

-1.0

(-25.3; 21.8)

– 3%

0.999

CBI

24.5

(9.3; 47.8)

34.5

(12.5; 47.7)

4.5

(-23.5; 12.0)

18%

*Lower scores represent better function; ** Higher scores represent better function


Disclosure:

S. R. Piva,
None;

M. B. Catelani,
None;

G. J. Almeida,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/comprehensive-behavioral-intervention-compared-to-standard-of-care-exercise-program-after-total-knee-arthroplasty-a-pilot-randomized-trial/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology